People | June 04, 2026
Dr. Saurabh Lall joins KIMS Hospitals as Chief Operating Officer
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
The move signals a major expansion in access to next-generation weight-loss therapies
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
Subscribe To Our Newsletter & Stay Updated
